DNDi aims to deliver:

  • A new oral, short-course macrofilaricide or long-term sterilizing treatment, with potential application to treat both onchocerciasis and lymphatic filariasis.

 

The current filarial diseases portfolio includes:

Research

Discovery

Macro Filaricide 3
Screening

Translation

Translation

ABBV-4083
Emodepside
Oxfendazole

 

For more details on each project, see DNDi‘s Global Portfolio